BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

29 related articles for article (PubMed ID: 5705722)

  • 1. [Clinical results with trifluoperidol in schizophrenic patients].
    Navarro MP; Assis LM; Martins C
    Rev Assoc Med Bras; 1966 Dec; 12(12):497-501. PubMed ID: 5241539
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparison of triperidol with perphenazine in schizophrenic psychoses. Effect on the photomyoclonic threshold].
    Náhunek K; Hádlík J; Rodová A; Misurec J; Vanýsek J
    Act Nerv Super (Praha); 1970 Jan; 12(1):56-7. PubMed ID: 4907390
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparison of the therapeutic effect of triperidol with perphenazine in schizophrenia].
    Náhunek K; Hádlik J; Svestka J; Rodová A; Vanýsek J
    Cesk Psychiatr; 1969 Oct; 65(5):281-9. PubMed ID: 5363280
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of trifluperidol (R 2498) on the urinary elimination of bufotenin in schizophrenia.
    Acebal EM; Spatz H
    Int J Neuropsychiatry; 1967 Dec; 3(6):472-6. PubMed ID: 5583441
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of trifluperidol in chronic schizaphrenia.
    Clark ML; Huber WK; Kyriakopoulos AA; Ray TS; Colmore JP; Ramsey HR
    Psychopharmacologia; 1968; 12(3):193-203. PubMed ID: 4917285
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of schizophrenic patients with triperidol (trisedil)].
    Ezhkov AA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1968; 68(9):1394-400. PubMed ID: 5705722
    [No Abstract]   [Full Text] [Related]  

  • 7. Central effects of metronidazole.
    Itil TM; Holden JM; Keskiner A; Shapiro D
    Psychiatr Res Rep Am Psychiatr Assoc; 1968 Mar; 24():148-65. PubMed ID: 4888685
    [No Abstract]   [Full Text] [Related]  

  • 8. Psychopharmacology and psychopathology.
    Cole JO
    Proc Annu Meet Am Psychopathol Assoc; 1969; 58():253-65. PubMed ID: 4898738
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug therapy.
    Hofling CK; Winslow WW; Stone WN
    Prog Neurol Psychiatry; 1969; 24():478-97. PubMed ID: 4905451
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pharmacological standards in schizophrenia treatment].
    Jarema M; Kiejna A; Landowski J; Meder J; Jolanta RJ; Rybakowski J
    Psychiatr Pol; 2006; 40(6):1171-205. PubMed ID: 17444297
    [No Abstract]   [Full Text] [Related]  

  • 11. [Antidepressant treatment of schizophrenic patients].
    Caroli F; Baldacci-Epinette C; Ribeyre P
    Encephale; 1993 Jul; 19 Spec No 2():393-6. PubMed ID: 7904237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Schizophrenia: value and limits of antidepressant drugs].
    Péron-Magnan P
    Encephale; 1995 Feb; 21 Spec No 1():49-53. PubMed ID: 7729357
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.